Page last updated: 2024-10-30

loxoprofen and Diffuse Parenchymal Lung Disease

loxoprofen has been researched along with Diffuse Parenchymal Lung Disease in 1 studies

loxoprofen: RN given refers to parent cpd without isomeric designation; structure in first source
loxoprofen : A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-[(2-oxocyclopentyl)methyl]phenyl group. A prodrug that is rapidly converted into its active trans-alcohol metabolite following oral administration.

Research Excerpts

ExcerptRelevanceReference
"Loxoprofen is a nonsteroidal anti-inflammatory drug used in the treatment of many diseases."1.43Loxoprofen-induced interstitial pneumonia: a case report. ( Arano, N; Jo, H; Kato, M; Kuriyama, S; Muraki, K; Nagashima, O; Sasaki, S; Sekimoto, Y; Suina, K; Takahashi, K; Tominaga, S; Yoshioka, Y, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kato, M1
Sasaki, S1
Sekimoto, Y1
Arano, N1
Jo, H1
Suina, K1
Kuriyama, S1
Muraki, K1
Nagashima, O1
Yoshioka, Y1
Tominaga, S1
Takahashi, K1

Other Studies

1 other study available for loxoprofen and Diffuse Parenchymal Lung Disease

ArticleYear
Loxoprofen-induced interstitial pneumonia: a case report.
    Journal of medical case reports, 2016, May-25, Volume: 10, Issue:1

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Lung Diseases, Interstitial; Phenylpr

2016